Sep 09, 2025 20:01
LUCD - Lucid Diagnostics Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
1.21 0.05 (4.13%) | --- | 0.0 (0.0%) | 0.01 (0.8%) | 0.0 (0.0%) | 0.06 (5.42%) | -0.01 (-0.69%) | -0.01 (-0.69%) |
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.08
- Diluted EPS:
- -0.08
- Basic P/E:
- -15.75
- Diluted P/E:
- -15.75
- RSI(14) 1m:
- 100.0
- VWAP:
- 1.26
- RVol:
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Oct 31, 2024 12:31
Oct 09, 2024 17:46
May 17, 2023 16:00
Mar 29, 2022 13:18
Nov 08, 2021 13:24
Nov 07, 2021 12:14
Nov 06, 2021 13:35
Oct 18, 2021 21:45